Key stats
About Franklin Genomic Advancements ETF
Home page
Inception date
Feb 25, 2020
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
Franklin Advisers, Inc.
Distributor
Franklin Distributors LLC
ISIN
US35473P5200
HELX invests in global companies benefitting from the advancements of genomic-based research techniques and technologies that are designed to extend or enhance the quality of life. The fund advisor uses fundamental research to identify and select stocks they feel best positioned to capitalize on such genomic advancements. Companies may include those that research, develop, produce or manufacture bionic devices, molecular medicine, pharmaceuticals and agricultural applications. HELX is one of the first three thematic funds to launch from Franklin Templeton.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Health Services
Stocks98.65%
Health Technology69.06%
Health Services14.14%
Technology Services6.41%
Commercial Services5.77%
Process Industries2.78%
Electronic Technology0.49%
Bonds, Cash & Other1.35%
Cash1.35%
Stock breakdown by region
North America84.63%
Europe11.49%
Asia3.88%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
HELX invests in stocks. The fund's major sectors are Health Technology, with 69.06% stocks, and Health Services, with 14.14% of the basket. The assets are mostly located in the North America region.
HELX top holdings are Natera, Inc. and Alnylam Pharmaceuticals, Inc, occupying 6.34% and 4.74% of the portfolio correspondingly.
HELX last dividends amounted to 0.00 USD. The year before, the issuer paid 0.11 USD in dividends, which shows a 2.80 K% decrease.
HELX assets under management is 17.05 M USD. It's risen 13.74% over the last month.
HELX fund flows account for 7.39 M USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
HELX shares are issued by Franklin Resources, Inc. under the brand Franklin. The ETF was launched on Feb 25, 2020, and its management style is Active.
HELX expense ratio is 0.50% meaning you'd have to pay 0.50% of your investment to help manage the fund.
HELX follows the No Underlying Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
HELX invests in stocks.
HELX price has risen by 3.33% over the last month, and its yearly performance shows a −6.00% decrease. See more dynamics on HELX price chart.
NAV returns, another gauge of an ETF dynamics, showed a 14.09% increase in three-month performance and has decreased by −5.97% in a year.
NAV returns, another gauge of an ETF dynamics, showed a 14.09% increase in three-month performance and has decreased by −5.97% in a year.
HELX trades at a premium (0.09%) meaning the ETF is trading at a higher price than the calculated NAV.